Literature DB >> 16758420

Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.

Lynn W Kitchen1, David W Vaughn, Donald R Skillman.   

Abstract

US military physicians and researchers helped identify the optimum treatment dose of the naturally occurring compound quinine and collaborated with the pharmaceutical industry in the development and eventual US Food and Drug Administration approval of the synthetic antimalarial drugs chloroquine, primaquine, chloroquine-primaquine, sulfadoxine-pyrimethamine, mefloquine, doxycycline, halofantrine, and atovaquone-proguanil. Because malaria parasites develop drug resistance, the US military must continue to support the creation and testing of new drugs to prevent and treat malaria until an effective malaria vaccine is developed. New antimalarial drugs also benefit civilians residing in and traveling to malarious areas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758420     DOI: 10.1086/504873

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  A lesson learnt: the rise and fall of Lariam and Halfan.

Authors:  Ashley M Croft
Journal:  J R Soc Med       Date:  2007-04       Impact factor: 5.344

2.  Neuropsychiatric Outcomes After Mefloquine Exposure Among U.S. Military Service Members.

Authors:  Angelia A Eick-Cost; Zheng Hu; Patricia Rohrbeck; Leslie L Clark
Journal:  Am J Trop Med Hyg       Date:  2016-11-14       Impact factor: 2.345

Review 3.  The Global Emerging Infection Surveillance and Response System (GEIS), a U.S. government tool for improved global biosurveillance: a review of 2009.

Authors:  Kevin L Russell; Jennifer Rubenstein; Ronald L Burke; Kelly G Vest; Matthew C Johns; Jose L Sanchez; William Meyer; Mark M Fukuda; David L Blazes
Journal:  BMC Public Health       Date:  2011-03-04       Impact factor: 3.295

4.  Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.

Authors:  Remington L Nevin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-04-05       Impact factor: 4.077

5.  Regulation of extracellular ATP in human erythrocytes infected with Plasmodium falciparum.

Authors:  Cora Lilia Alvarez; Julieta Schachter; Ana Acacia de Sá Pinheiro; Leandro de Souza Silva; Sandra Viviana Verstraeten; Pedro Muanis Persechini; Pablo Julio Schwarzbaum
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

6.  Emerging and re-emerging infectious diseases: challenges and opportunities for militaries.

Authors:  Zheng Jie Marc Ho; Yi Fu Jeff Hwang; Jian Ming Vernon Lee
Journal:  Mil Med Res       Date:  2014-09-24

7.  Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.

Authors:  Jérémy Spalenka; Sandie Escotte-Binet; Ali Bakiri; Jane Hubert; Jean-Hugues Renault; Frédéric Velard; Simon Duchateau; Dominique Aubert; Antoine Huguenin; Isabelle Villena
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

8.  Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.

Authors:  W Zheng; H Jiang; Z Xiong; Z Jiang; H Chen
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

Review 9.  Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force.

Authors:  Stuart McCarthy
Journal:  J Parasitol Res       Date:  2015-12-17

10.  A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.

Authors:  Joy Wolfram; Sara Nizzero; Haoran Liu; Feng Li; Guodong Zhang; Zheng Li; Haifa Shen; Elvin Blanco; Mauro Ferrari
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.